From: Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency
 | 25(OH)D < 30 ng/ml | 25(OH)D ≥ 30 ng/ml | p-value |
---|---|---|---|
Allergy | Â | Â | Â |
Yes | 159 (67.4%) | 77 (32.6%) | Â |
No | 28 (66.7%) | 14 (33.3%) | 0.359 |
OCS use | Â | Â | Â |
Yes | 58 (77.3%) | 17 (22.7%) | Â |
No | 130 (63.4%) | 75 (36.6%) | 0.031 |
OCS dose (mg/d) | 24 ± 29 | 16 ± 12 | 0.274 |
ICS use | Â | Â | Â |
Yes | 150 (68.2%) | 70 (31.8%) | Â |
No | 38 (63.3%) | 22 (36.7%) | 0.536 |
ICS dose (μg/d) | 1310 ± 815 | 1232 ± 916 | 0.547 |
Age (years) | 44.5 ± 13.0 | 46.0 ± 15.4 | 0.400 |
FEV1 (L) | 2.3 ± 0.9 | 2.7 ± 1.0 | 0.003 |
FEV1 (%) | 71.7 ± 23.4 | 81.4 ± 22.3 | 0.001 |
Reversibility (%) | 13.1 ± 22.7 | 12.2 ± 23.3 | 0.838 |
Exhaled NO (ppb) | 45 ± 46 | 31 ± 27 | 0.022 |
Total IgE (IU/ml) | 544 ± 1292 | 365 ± 689 | 0.230 |
Duration of disease (years) | 18.6 ± 13.5 | 17.5 ± 15.5 | 0.539 |
Sputum eosinophilia | Â | Â | Â |
Yes | 21 (95.5%) | 1 (4.5%) | Â |
No | 36 (66.7%) | 18 (33.3%) | 0.008 |
Sputum eosinophils (%) | 5.1 ± 11.9 | 0.5 ± 1.0 | 0.005 |
BMI (kg/m 2 ) | 28.3 ± 6.3 | 25.1 ± 3.9 | <0.001 |
IL-10 (ng/ml) | 118.6 ± 122.6 | 114.2 ± 137.1 | 0.788 |